AppFolio Inc. reported a 22% year-over-year revenue surge in its fourth quarter, driven by AI innovation and premium product adoption, while navigating industry-wide cost pressures. The company also issued optimistic guidance for 2026.
Despite a powerful multi-year rally, new analysis suggests The Hartford's stock may still be trading at a significant discount. We examine the valuation metrics and market sentiment surrounding the insurance giant.
Proposed flat payment rates for 2027 by CMS intensify margin pressures on Medicare Advantage insurers like Clover Health, raising investor concerns about cost management and growth prospects in a tightening regulatory landscape.
Lazard Ltd. reported strong fourth-quarter and full-year 2025 results, driven by record financial advisory fees and a rebound in assets under management. Executives framed the performance as validation of the firm's long-term 'Lazard 2030' strategy, highlighting talent investments and a robust pipeline for future growth.
Shares of Norwegian Cruise Line Holdings (NCLH) soared over 10% Thursday, buoyed by robust industry-wide demand and positive spillover from a rival's record earnings, signaling a potential turnaround for the cruise sector.
Bitcoin plunged to a nine-month low as a confluence of political uncertainty and geopolitical tensions sparked a broad market sell-off, forcing over $1.6 billion in leveraged positions to close.
Carnival Corporation & PLC saw its stock price climb sharply Thursday, buoyed by robust earnings from rival Royal Caribbean and the company's own announcement of a planned corporate unification and dividend payment.
Vizsla Silver Corp. (VZLA) shares tumbled sharply Thursday after reports that 10 of its employees were abducted from company housing in Mexico, forcing a temporary halt to operations and rattling investor confidence amid broader weakness in silver prices.
Olin Corporation's (NYSE: OLN) stock performance tells a conflicting story: a recent monthly gain contrasts sharply with steep multi-year declines. A deep dive into the numbers reveals a stark divide between cash flow-based and earnings-based valuation models, leaving investors to question where true value lies in the volatile chemicals sector.
The Swedish industrial giant reported lower sales and net income for 2025 but proposed maintaining its ordinary dividend and adding a special distribution, a move analysts interpret as a show of financial strength despite near-term headwinds.
After a stellar multi-year run, Airbus shares have retreated recently, prompting investors to reassess the European aerospace champion's valuation. Analysis suggests the stock may be trading at a significant discount to its intrinsic value, even as it navigates production challenges and a robust order book.
Crocs shares have tumbled nearly 23% over the past year, raising questions about the iconic footwear brand's valuation. While a key financial model suggests the stock is deeply undervalued, market sentiment tells a more cautious story. We examine the numbers and the narratives shaping investor debate.
Aptiv PLC (APTV) presents a puzzle for investors: a widely cited discounted cash flow model suggests significant upside, yet its premium valuation multiples tell a more cautious tale. As the automotive technology supplier navigates its EDS separation and bets on software-defined vehicles, the market weighs short-term momentum against long-term execution risks.
GSK makes a dual strategic move, acquiring RAPT Therapeutics for its food allergy portfolio and securing broader European approval for its RSV vaccine Arexvy, reinforcing its focus on immunology and respiratory health.
Marriott International's shares have delivered impressive multi-year gains, but recent analysis suggests the hospitality giant's stock may now be trading at a significant premium. With a DCF model pointing to a 16% overvaluation and a P/E ratio exceeding industry peers, investors are debating whether the price fully reflects future growth or has outpaced fundamentals.
Disney's newly appointed Chief Marketing and Brand Officer, Asad Ayaz, has restructured the company's global marketing leadership, creating a new enterprise team to foster collaboration and a unified brand voice across all divisions.
Brunswick Corporation (NYSE: BC) closed its 2025 fiscal year on a confident note, citing a resilient recovery in the marine market, a historic surge in free cash flow, and significant debt reduction. While navigating persistent tariff headwinds, the company's leadership pointed to stabilizing retail demand and strategic market share gains as key drivers for cautious optimism heading into 2026.
British pharmaceutical giant AstraZeneca has entered a strategic partnership with China's CSPC Pharmaceutical, committing over $1 billion upfront to co-develop next-generation obesity therapies, signaling intensified competition in the lucrative global weight-loss drug market.
With his term winding down, Federal Reserve Chair Jerome Powell offered rare, pointed advice to his eventual successor during a recent press conference, emphasizing the imperative of maintaining the central bank's independence from political influence.
The defense giant's stock jumped over 4% following an optimistic sales forecast and a major new agreement to significantly boost production of a key missile defense system for the U.S. military.
